PP
PDT Partners Portfolio holdings
AUM
$1.77B
1-Year Return
43.53%
This Quarter Return
+9.85%
1 Year Return
+43.53%
3 Year Return
+141.92%
5 Year Return
+251.03%
10 Year Return
+895.15%
AUM
$1.13B
AUM Growth
+$72.2M
(+6.8%)
Cap. Flow
+$12.1M
Cap. Flow
% of AUM
1.07%
Top 10 Holdings %
Top 10 Hldgs %
7.17%
Holding
858
New
204
Increased
192
Reduced
260
Closed
148
Top Buys
| 1 |
VF Corp
VFC
|
$5.61M |
| 2 |
Williams Companies
WMB
|
$5M |
| 3 |
Inspire Medical Systems
INSP
|
$4.94M |
| 4 |
Corning
GLW
|
$4.25M |
| 5 |
SentinelOne
S
|
$4.13M |
Top Sells
| 1 |
Spotify
SPOT
|
$8M |
| 2 |
Uber
UBER
|
$6.05M |
| 3 |
Robinhood
HOOD
|
$5.95M |
| 4 |
Atlassian
TEAM
|
$5.66M |
| 5 |
Cushman & Wakefield
CWK
|
$4.86M |
Sector Composition
| 1 | Healthcare | 20.98% |
| 2 | Technology | 20.93% |
| 3 | Industrials | 14.23% |
| 4 | Consumer Discretionary | 11.37% |
| 5 | Financials | 10.79% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
226
Klaviyo
KVYO
$9.66B
| $1.84M | 0.16% |
52,098
-7,500
| -13% | -$265K |
|
227
AvidXchange
AVDX
$2.06B
| $1.84M | 0.16% |
+226,373
| New | +$1.84M |
|
228
Clearway Energy Class C
CWEN
$3.38B
| $1.83M | 0.16% |
59,791
+14,058
| +31% | +$431K |
|
229
Astera Labs
ALAB
$31.8B
| $1.83M | 0.16% |
+35,000
| New | +$1.83M |
|
230
LendingClub
LC
$1.9B
| $1.83M | 0.16% |
160,127
+36
| +0% | +$411 |
|
231
Charles River Laboratories
CRL
$8.07B
| $1.82M | 0.16% |
9,263
-3,500
| -27% | -$689K |
|
232
Mueller Water Products
MWA
$4.19B
| $1.81M | 0.16% |
+83,385
| New | +$1.81M |
|
233
Varex Imaging
VREX
$484M
| $1.8M | 0.16% |
+151,211
| New | +$1.8M |
|
234
Universal Health Services
UHS
$12.1B
| $1.8M | 0.16% |
7,842
| – | – |
|
235
Hudbay
HBM
$5.03B
| $1.79M | 0.16% |
194,382
+47,155
| +32% | +$433K |
|
236
Avidity Biosciences
RNA
$6.48B
| $1.78M | 0.16% |
38,846
-9
| -0% | -$413 |
|
|
HCP
237
DELISTED
HashiCorp, Inc. Class A Common Stock
HCP
| $1.78M | 0.16% |
52,605
-36,379
| -41% | -$1.23M |
|
238
Gilead Sciences
GILD
$143B
| $1.77M | 0.16% |
+21,107
| New | +$1.77M |
|
239
NovoCure
NVCR
$1.37B
| $1.75M | 0.16% |
112,083
-76,339
| -41% | -$1.19M |
|
240
Marsh & McLennan
MMC
$100B
| $1.75M | 0.16% |
7,850
-33
| -0.4% | -$7.36K |
|
241
ICU Medical
ICUI
$3.24B
| $1.75M | 0.16% |
9,610
+1
| +0% | +$182 |
|
242
Enerpac Tool Group
EPAC
$2.3B
| $1.75M | 0.16% |
41,797
-75
| -0.2% | -$3.14K |
|
243
Arcturus Therapeutics
ARCT
$485M
| $1.74M | 0.15% |
+75,144
| New | +$1.74M |
|
244
Replimune Group
REPL
$494M
| $1.74M | 0.15% |
158,770
| – | – |
|
245
Abbott
ABT
$231B
| $1.73M | 0.15% |
15,200
-8,500
| -36% | -$969K |
|
246
Hilton Worldwide
HLT
$64B
| $1.73M | 0.15% |
7,501
+99
| +1% | +$22.8K |
|
247
Levi Strauss
LEVI
$8.79B
| $1.73M | 0.15% |
79,243
+129
| +0.2% | +$2.81K |
|
248
Jack Henry & Associates
JKHY
$11.8B
| $1.72M | 0.15% |
+9,762
| New | +$1.72M |
|
249
Neurocrine Biosciences
NBIX
$14.3B
| $1.72M | 0.15% |
+14,900
| New | +$1.72M |
|
250
Brookfield
BN
$99.5B
| $1.72M | 0.15% |
32,300
-21,563
| -40% | -$1.15M |
|